Legendary cannabis researcher, Professor Raphael Mechoulam of The Hebrew University of Jerusalem’s Institute for Drug Research, is globally acknowledged as the father of cannabinoid research. His pioneering work has proven to be of central importance in pharmacology, physiology, and medicine. Raphi's research focuses on the chemistry of natural substances, their biological function, and the development of new potential drugs. He is best known for developing the chemistry, biochemistry, and medicinal chemistry of cannabinoid compounds of plant origin.
Last week Professor Raphael Mechoulam spoke at the ICRS Symposium, which was held worldwide, broadcasted from Jerusalem, and represented 50+ countries. It was brilliant! The International Cannabinoid Research Society is a non-political, non-religious organization dedicated to scientific research in all fields of cannabinoids, with more than 650 international Members researching the endogenous, plant-derived and synthetic cannabinoids and related bioactive lipids.
You can learn more about ICRS here.
Known for solutions that yield results, Seth Yakatan has completed or advised on acquisitions and corporate finance transactions totaling over $3 billion. He is CEO of Katan Associates International—a financial strategy and merchant banking firm specializing in commercialization and asset monetization—especially those within life-science and e-commerce sectors.